Aktive farmaceutiske ingredienser
Gestagen og østrogen | |||
Produktnavn | Specifikation | Godkendt | CAS-nr. |
Progesteron | CP/EP/USP | CEP/EU-GMP/FDA | 57-83-0 |
Pregnenolon | In-house |
Kosher | 145-13-1 |
Medroxyprogesteron Acetat | CP/EP/USP | DMF/GMP | 71-58-9 |
Megestrolacetat | CP/EP/USP | DMF i gang | 595-33-5 |
Mifepriston | CP/IP | DMF/GMP | 84371-65-3 |
Cyproteronacetat | CP/EP | CEP/TGA/EU-GMP | 427-51-0 |
Levonorgestrel | CP/EP/USP | CEP/GMP | 797-63-7 |
Drospirenon | EP/USP | DMF | 67392-87-4 |
Gestodene | CP/EP | DMF/GMP | 60282-87-3 |
Østradiol | CP/EP/USP | DMF/GMP | 35380-71-3 |
Estriol | CP/EP/USP | Under R&D | 50-27- 1 |
Ethinylestradiol | CP/EP/USP | GMP | 57-63-6 |
Østradiol Valerat | CP | DMF | 979-32-8 |
Tibolone | CP/EP | DMF/GMP | 5630-53-5 |
Dienogest | EP | CEP | 65928-58-7 |
Fulvestrant | In-house | Under R&D | 129453-61-8 |
Exemestan | EP/USP | Under R&D | 107868-30-4 |
androgen | |||
Produktnavn | Specifikation | Godkendt | CAS-nr. |
Finasteride | CP/EP/USP | CEP/FDA/PMDA/GMP | 98319-26-7 |
Dutasteride | EP/USP | CEP/FDA | 164656-23-9 |
Abirateronacetat | CP/USP | DMF/WC | 154229-18-2 |
Testosteron | CP/EP/USP | CEP/WC/FDA | 58-22-0 |
Testosteron undecanoat | CP | DMF/WC | 5949-44-0 |
Testosteron Cypionate | USP | Under R&D | 58-20-8 |
DHEA (prasteron) | FP/In-house | DMF/WC/Kosher | 53-43-0 |
Clascoterone | In-house | DMF i gang | 19608-29-8 |
Kortikalt hormon | |||
Produktnavn | Specifikation | Godkendt | CAS-nr. |
Budesonid | CP/EP/USP | CEP/FDA/GMP | 51333-22-3 |
Desonid | USP | DMF/GMP | 638-94-8 |
Eplerenon | EP | CEP i gang | 107724-20-9 |
Methylprednisolon | CP/EP/USP | DMF/GMP | 83-43-2 |
Methylprednisolon Hemisuccinat | CP/EP/USP | DMF/GMP | 2921-57-5 |
Fluticasonpropionat | CP/EP/USP | DMF | 80474-14-2 |
Flutikasonfuroat | In-house | DMF i gang | 397864-44-7 |
Mometasonfuroat |
EP/USP |
DMF i gang |
Vandfri (83919-23-7) Monohydrat (141646-00-6) |
Andre | |||
Produktnavn | Specifikation | Godkendt | CAS-nr. |
Oxcarbazepin | CP/EP/USP | CEP/FDA | 28721-07-5 |
Eslicarbazepinacetat | In-house | DMF | 236395-14-5 |
Ganciclovir | CP/EP/USP | DMF/GMP | 82410-32-0 |
Valganciclovir Hydrochlorid | USP | DMF | 175865-59-5 |
Oseltamivir fosfat | CP/EP/USP | DMF | 204255-11-8 |
Baloxavir Marboxil | In-house | Under R&D | 1985606-14-1 |
Nintedanib Esylate | In-house | DMF/FDA | 656247-18-6 |
Revefenacin | In-house | DMF | 864750-70-9 |
Mirabegron | In-house | DMF | 223673-61-8 |
Escitalopram Oxalat | EP/USP/CP | DMF i gang | 219861-08-2 |
Cariprazin hydrochlorid | In-house | DMF | 1083076-69-0 |
Lasmiditansuccinat | In-house | DMF | 439239-92-6 |
Luliconazol | In-house | DMF | 187164-19-8 |
Apalutami | In-house | DMF i gang | 956104-40-8 |
Tadalafil | EP/USP/CP | Under R&D | 171596-29-5 |
Relugolix | In-house | DMF i gang | 737789-87-6 |
Phloroglucinol | CP | DMF | 108-73-6 |
Ursodeoxycholsyre | EP/USP/JP | Under R&D | 128-13-2 |
Omega-3-syre ethylethere 90 |
EP/USP |
DMF i gang |
—— |
Mellemkædede triglycerider |
CP/USP/EP |
DMF |
—— |
Benzalkoniumchlorid |
USP/EP/JP |
CEP i gang |
8001-54-5 |
Olivenolie (til injektion) |
CP/USP/EP/JP |
DMF i gang |
8001-25-0 |
Ægfosfolipider (til injektion) |
CP/USP/EP |
DMF |
93685-90-6 |
MELLEMMÅLTID |
In-house |
DMF i gang |
203787-91-1 |
For Methylprednisolone Hemisuccinate har vi EP-, USP- og CP-specifikationer. DMF og toilet til rådighed.
For Cyproterone Acetate (CPA) har vi CP- og EP-specifikationer, CEP/TGA/EU-GMP tilgængelige.
Levonorgestrel har specifikationer af CP/EP/USP. DMF, GMP og CEP tilgængelige.
Mifepriston har specifikationer af CP og IP.DMF og GMP godkendt.
Tibolone overholder EP-specifikationen. DMF er godkendt.
Estradiol Hemihydrate har USP og EP specifikation. DMF tilgængelig.